CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

LIFE Corporation

LIFE Corporation is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medinomics

Medinomics is a Shreveport, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals researches and manufactures biotherapeutic products with a specialization in immunology and liver transplant therapy.

Peconic Landing

Offering the benefits of resort-style amenities and an independent lifestyle, with access to award-winning lifecare services providing added peace of mind.

Mercy Mc Mahon Terrace

Mercy Mc Mahon Terrace is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.